fbpx

Author: Mathew Halpert, PhD

Dendritic Cells and Their Therapeutic Role in Prostate Cancer

In 2022, almost 270,000 American men will be diagnosed with prostate cancer, and about 35,000 prostate cancer patients will succumb to the disease.

READ THIS NEXT

What Is Immunotherapy?

In the late 1800’s Dr. William Coley stumbled onto an interesting observation, that an active immune response in the area of a tumor could delay and even occasionally eliminate a cancerous threat1, 2.

READ THIS NEXT

Is Alternative Cancer Treatment Safe and Effective?

As we now live in an age in which information freely flows and all manners of hyperbole are available at our fingertips through our screens, it is hard to know what is “real” and what is “fake.” Patients that receive a cancer diagnosis often find themselves scouring the corners of the internet attempting to find a better treatment option or something that ensures their odds of survival, only to be met with a smattering of anecdotes, reviews on all extremes, and no real idea what path they should take.

READ THIS NEXT

Cancer Cells Hiding in Other Cancer Cells?

As we outlined in our post dedicated to Head & Neck Cancer, the Immune System has the inherent ability to find and destroy cancer cells. In fact, it does this for you every day! Since humans already have this natural ability, scientists are continually researching why cancer cells are able to avoid detection and ultimately grow into tumors.

READ THIS NEXT

The Misconception of Checkpoint Inhibitors

As the earliest form of commercialized Immunotherapy, Checkpoint Inhibitors laid the foundation for Immunotherapy as a viable cancer treatment. Further, Checkpoint Inhibitors are able to be produced in bulk and are relatively safe especially when compared to Chemotherapy.

READ THIS NEXT

Understanding Immunotherapy with World Renowned Author, Haylie Pomroy

The Immunocine Team’s Dr. Matt Halpert and Dr. Rafael Gonzalez recently recorded a podcast with #1 NYT Best Selling Author and Celebrity Nutritionist, Haylie Pomroy.

READ THIS NEXT

Stage 4 Prostate Cancer Patient Update after 5 Years

In 2014, Chris had Stage 4 Metastatic Prostate Cancer that had spread throughout his body. His physicians gave Chris less than 3 years to live. While he had seen initial results with Chemotherapy, his cancer progressed to over 30 tumors located throughout his body.

READ THIS NEXT

Using Dendritic Cells to Fight Head and Neck Cancers

Head and Neck Cell Cancers (HNC) includes cancers within the oral cavity, sinonasal cavities, pharynx and larynx. HNC is the 6th most common cancer in the world with roughly 550,000 diagnoses each year.

READ THIS NEXT

Advances in Treating Triple-Negative Breast Cancer

Triple-negative breast cancer is a unique form of breast cancer lacking in typical receptors found on these breast cells. Despite its difficulty in treating, the Immunocine Cancer Center’s treatment has had demonstrated success in treating triple-negative cancer patients.

READ THIS NEXT